Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era

Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 32; no. 9; pp. 1445 - 1450
Main Authors Lee, Shinwon, Lee, Sun Hee, Lee, Jeong Eun, Kang, Jin Suk, Lee, Seung Geun, Chung, Joo Seop, Kwak, Ihm Soo
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 01.09.2017
대한의학회
Subjects
Online AccessGet full text
ISSN1011-8934
1598-6357
1598-6357
DOI10.3346/jkms.2017.32.9.1445

Cover

Abstract Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0-14.3), 4.5 (95% CI, 2.8-7.0), and 6.3 (95% CI, 4.2-9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea.
AbstractList Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0-14.3), 4.5 (95% CI, 2.8-7.0), and 6.3 (95% CI, 4.2-9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea.
Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0–14.3), 4.5 (95% CI, 2.8–7.0), and 6.3 (95% CI, 4.2–9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea. KCI Citation Count: 0
Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0-14.3), 4.5 (95% CI, 2.8-7.0), and 6.3 (95% CI, 4.2-9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea.Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been extended significantly. Therefore, the importance of non-AIDS-defining cancers (NADCs), as well as AIDS-defining cancers (ADCs) has increased. There is little information concerning the epidemiology of malignancies in PWHA in Korea. A descriptive epidemiologic study was conducted at a tertiary care hospital in Korea. PWHA who visited Pusan National University Hospital from January 2000 to October 2014 were included. Demographics and clinical data were obtained from the medical records and analyzed. A total of 950 PWHA were observed for 4,439.71 person-years. Forty-eight episodes (5.05%) of cancers were diagnosed in 47 patients. Mean age of the enrolled patients was 40.66 ± 12.15 years and 88% were male. Among the 48 cancer episodes, 20 (42%) were ADCs and 28 were NADCs. The most common ADCs was non-Hodgkin's lymphoma (53.6%), followed by Kaposi's sarcoma (17.9%). The most common NADCs were lung cancer (25%) and hepatocellular carcinoma (25%). The overall incidence of total cancers, ADCs, and NADCs was 10.8 (95% confidence interval [CI], 8.0-14.3), 4.5 (95% CI, 2.8-7.0), and 6.3 (95% CI, 4.2-9.1)/1,000 person-years, respectively. NADCs accounted for 12/15 (80%) of cancers among PWHA with good adherence to care. The 5-year survival rate of PWHA and NADC was 26.3%. NADCs have become the main type of malignancy among Korean PWHA with good adherence to care. Effective strategies to improve screening of NADCs among PWHA are required in Korea.
Author Kang, Jin Suk
Lee, Jeong Eun
Lee, Sun Hee
Lee, Seung Geun
Chung, Joo Seop
Lee, Shinwon
Kwak, Ihm Soo
AuthorAffiliation Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
AuthorAffiliation_xml – name: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
Author_xml – sequence: 1
  givenname: Shinwon
  orcidid: 0000-0001-7652-7093
  surname: Lee
  fullname: Lee, Shinwon
  organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 2
  givenname: Sun Hee
  orcidid: 0000-0003-2093-3628
  surname: Lee
  fullname: Lee, Sun Hee
  organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 3
  givenname: Jeong Eun
  orcidid: 0000-0003-3027-1381
  surname: Lee
  fullname: Lee, Jeong Eun
  organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 4
  givenname: Jin Suk
  orcidid: 0000-0002-4137-5453
  surname: Kang
  fullname: Kang, Jin Suk
  organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 5
  givenname: Seung Geun
  orcidid: 0000-0002-5205-3978
  surname: Lee
  fullname: Lee, Seung Geun
  organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 6
  givenname: Joo Seop
  orcidid: 0000-0001-7008-245X
  surname: Chung
  fullname: Chung, Joo Seop
  organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
– sequence: 7
  givenname: Ihm Soo
  orcidid: 0000-0002-8022-9205
  surname: Kwak
  fullname: Kwak, Ihm Soo
  organization: Deparment of Internal Medicine, Pusan National University School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28776339$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002256308$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9UkuP0zAQjtAi9gG_AAn5CIeG-Nn4glStFlqxCIQKV8t1Jq23id21naL-Av42TrusgAOnsTTfYzzzXRZnzjsoipe4Kill4u3dto8lqfC0pKSUJWaMPykuMJf1RFA-PcvvCuNJLSk7Ly5jvKsqwjmhz4pzUk-nglJ5UfxcBnBNRNahT7qza6edsRCR7r1bo48-gHboi04WXIpo4VowCRr0w6YNmg99bi76fnC-gdZmojMH9N2G4SiYNoDmdr3pDmhmkt0DmrlkA6Tg9zboDi03EPTugG6Cfl48bXUX4cVDvSq-vb9ZXs8nt58_LK5ntxPDqEyTVmuJxYqI_AFaNTXTANqwFWkhrwRLijVrhQC-kqxpa0YEbwHTCusVaFFRelW8Oem60Kqtscpre6xrr7ZBzb4uF4rwmnNRZ-y7E3Y3rHpoTF5Bnlrtgu11OByZf3ec3WSdveKcCSlGs9cPAsHfDxCT6m000HXagR-iwpIIUXMiZIa--tPr0eT3pTKAngAm-BgDtI8QXKkxD2rMgxrzoChRUo15yCz5D8vYlK_px4Ft91_uLyKuvxo
CitedBy_id crossref_primary_10_3947_ic_2019_51_1_35
crossref_primary_10_1038_s41598_022_14170_5
crossref_primary_10_1016_j_jiac_2022_04_015
crossref_primary_10_1177_23247096211065633
crossref_primary_10_1001_jamanetworkopen_2022_24897
crossref_primary_10_5812_archcid_98922
crossref_primary_10_1186_s12885_018_5019_9
crossref_primary_10_1016_j_jiac_2023_01_018
crossref_primary_10_1097_QAI_0000000000003389
Cites_doi 10.1056/NEJM199803263381301
10.1016/S0140-6736(14)60604-8
10.1177/135965350200700103
10.3346/jkms.2016.31.2.178
10.1016/S0140-6736(04)16593-8
10.1097/01.qai.0000233310.90484.16
10.1097/QAD.0000000000000163
10.1097/01.aids.0000238411.75324.59
10.1038/sj.bjc.6605756
10.1002/cncr.27694
10.1002/ijc.25153
10.1097/01.qai.0000232260.95288.93
10.3346/jkms.2013.28.7.990
10.1001/jama.279.6.450
10.3346/jkms.2013.28.1.67
10.1002/ijc.23487
10.1097/QAI.0000000000000065
10.1016/S0140-6736(16)31012-1
10.1093/jnci/92.22.1823
10.1200/JCO.2012.44.5486
10.7326/0003-4819-148-10-200805200-00005
10.1001/archinte.165.4.416
10.1016/S0140-6736(08)61113-7
10.4167/jbv.2016.46.4.283
ContentType Journal Article
Copyright 2017 The Korean Academy of Medical Sciences.
2017 The Korean Academy of Medical Sciences. 2017
Copyright_xml – notice: 2017 The Korean Academy of Medical Sciences.
– notice: 2017 The Korean Academy of Medical Sciences. 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3346/jkms.2017.32.9.1445
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1598-6357
EndPage 1450
ExternalDocumentID oai_kci_go_kr_ARTI_2585568
PMC5546963
28776339
10_3346_jkms_2017_32_9_1445
Genre Journal Article
GroupedDBID ---
29K
2WC
3O-
5-W
53G
5GY
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EF.
EJD
F5P
FRP
GROUPED_DOAJ
GX1
HYE
KQ8
M48
O5R
O5S
OK1
OVT
PGMZT
RNS
RPM
TR2
W2D
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
08R
ACYCR
M~E
ID FETCH-LOGICAL-c439t-faa916b2687730d84aeeac4b2fe3461931a4f66e5b94df84265fe1301abea6033
IEDL.DBID M48
ISSN 1011-8934
1598-6357
IngestDate Tue Nov 21 21:43:56 EST 2023
Tue Sep 30 15:35:03 EDT 2025
Fri Jul 11 04:52:50 EDT 2025
Mon Jul 21 06:02:38 EDT 2025
Tue Jul 01 01:44:59 EDT 2025
Thu Apr 24 22:51:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords AIDS
Malignancy
HIV
Antiretroviral Therapy
Language English
License 2017 The Korean Academy of Medical Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-faa916b2687730d84aeeac4b2fe3461931a4f66e5b94df84265fe1301abea6033
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7652-7093
0000-0002-8022-9205
0000-0002-5205-3978
0000-0002-4137-5453
0000-0003-3027-1381
0000-0003-2093-3628
0000-0001-7008-245X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2017.32.9.1445
PMID 28776339
PQID 1926685269
PQPubID 23479
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_2585568
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5546963
proquest_miscellaneous_1926685269
pubmed_primary_28776339
crossref_primary_10_3346_jkms_2017_32_9_1445
crossref_citationtrail_10_3346_jkms_2017_32_9_1445
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-09-01
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of Korean medical science
PublicationTitleAlternate J Korean Med Sci
PublicationYear 2017
Publisher The Korean Academy of Medical Sciences
대한의학회
Publisher_xml – name: The Korean Academy of Medical Sciences
– name: 대한의학회
References Choe (10.3346/jkms.2017.32.9.1445_ref20) 2006; 38
Hogg (10.3346/jkms.2017.32.9.1445_ref2) 1998; 279
Polesel (10.3346/jkms.2017.32.9.1445_ref12) 2010; 127
Seol (10.3346/jkms.2017.32.9.1445_ref21) 2009; 76
(10.3346/jkms.2017.32.9.1445_ref23) 2008; 372
Lee (10.3346/jkms.2017.32.9.1445_ref4) 2013; 28
Chen (10.3346/jkms.2017.32.9.1445_ref9) 2014; 65
Mocroft (10.3346/jkms.2017.32.9.1445_ref5) 2002; 7
d’Arminio Monforte (10.3346/jkms.2017.32.9.1445_ref1) 2005; 165
Ruxrungtham (10.3346/jkms.2017.32.9.1445_ref8) 2004; 364
(10.3346/jkms.2017.32.9.1445_ref24) 2016; 388
Palella (10.3346/jkms.2017.32.9.1445_ref6) 2006; 43
Piketty (10.3346/jkms.2017.32.9.1445_ref11) 2012; 30
Brock (10.3346/jkms.2017.32.9.1445_ref17) 2006; 43
Robbins (10.3346/jkms.2017.32.9.1445_ref25) 2014; 28
Patel (10.3346/jkms.2017.32.9.1445_ref16) 2008; 148
Palella (10.3346/jkms.2017.32.9.1445_ref7) 1998; 338
(10.3346/jkms.2017.32.9.1445_ref14) 2000; 92
(10.3346/jkms.2017.32.9.1445_ref22) 1992; 41
Engels (10.3346/jkms.2017.32.9.1445_ref10) 2008; 123
Kang (10.3346/jkms.2017.32.9.1445_ref29) 2016; 31
Lee (10.3346/jkms.2017.32.9.1445_ref3) 2013; 28
Franceschi (10.3346/jkms.2017.32.9.1445_ref19) 2010; 103
Sahasrabuddhe (10.3346/jkms.2017.32.9.1445_ref13) 2012; 118
Smith (10.3346/jkms.2017.32.9.1445_ref26) 2014; 384
Lee (10.3346/jkms.2017.32.9.1445_ref27) 2016; 46
Mitsuyasu (10.3346/jkms.2017.32.9.1445_ref18) 2008; 16
10.3346/jkms.2017.32.9.1445_ref28
Engels (10.3346/jkms.2017.32.9.1445_ref15) 2006; 20
15738371 - Arch Intern Med. 2005 Feb 28;165(4):416-23
23853480 - J Korean Med Sci. 2013 Jul;28(7):990-7
18435450 - Int J Cancer. 2008 Jul 1;123(1):187-94
23341714 - J Korean Med Sci. 2013 Jan;28(1):67-73
18657708 - Lancet. 2008 Jul 26;372(9635):293-9
12008784 - Antivir Ther. 2002 Mar;7(1):21-30
9466638 - JAMA. 1998 Feb 11;279(6):450-4
16936558 - J Acquir Immune Defic Syndr. 2006 Sep;43(1):47-55
16868446 - AIDS. 2006 Aug 1;20(12):1645-54
23091098 - J Clin Oncol. 2012 Dec 10;30(35):4360-6
15234860 - Lancet. 2004 Jul 3-9;364(9428):69-82
16878047 - J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34
20049835 - Int J Cancer. 2010 Sep 1;127(6):1437-45
18490686 - Ann Intern Med. 2008 May 20;148(10):728-36
27733281 - Lancet. 2016 Oct 8;388(10053):1459-1544
20588274 - Br J Cancer. 2010 Jul 27;103(3):416-22
1361652 - MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19
25042234 - Lancet. 2014 Jul 19;384(9939):241-8
18838745 - Top HIV Med. 2008 Oct-Nov;16(4):117-21
24300545 - AIDS. 2014 Mar 27;28(6):881-90
24583616 - J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):463-72
22736272 - Cancer. 2012 Dec 15;118(24):6226-33
26839469 - J Korean Med Sci. 2016 Feb;31(2):178-82
11078759 - J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30
9516219 - N Engl J Med. 1998 Mar 26;338(13):853-60
References_xml – volume: 338
  start-page: 853
  year: 1998
  ident: 10.3346/jkms.2017.32.9.1445_ref7
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199803263381301
– volume: 76
  start-page: 554
  year: 2009
  ident: 10.3346/jkms.2017.32.9.1445_ref21
  publication-title: Korean J Med
– volume: 384
  start-page: 241
  year: 2014
  ident: 10.3346/jkms.2017.32.9.1445_ref26
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)60604-8
– volume: 7
  start-page: 21
  year: 2002
  ident: 10.3346/jkms.2017.32.9.1445_ref5
  publication-title: Antivir Ther
  doi: 10.1177/135965350200700103
– volume: 31
  start-page: 178
  year: 2016
  ident: 10.3346/jkms.2017.32.9.1445_ref29
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2016.31.2.178
– volume: 364
  start-page: 69
  year: 2004
  ident: 10.3346/jkms.2017.32.9.1445_ref8
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)16593-8
– volume: 43
  start-page: 27
  year: 2006
  ident: 10.3346/jkms.2017.32.9.1445_ref6
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/01.qai.0000233310.90484.16
– volume: 38
  start-page: 367
  year: 2006
  ident: 10.3346/jkms.2017.32.9.1445_ref20
  publication-title: Infect Chemother
– volume: 28
  start-page: 881
  year: 2014
  ident: 10.3346/jkms.2017.32.9.1445_ref25
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000000163
– volume: 20
  start-page: 1645
  year: 2006
  ident: 10.3346/jkms.2017.32.9.1445_ref15
  publication-title: AIDS
  doi: 10.1097/01.aids.0000238411.75324.59
– volume: 103
  start-page: 416
  year: 2010
  ident: 10.3346/jkms.2017.32.9.1445_ref19
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6605756
– volume: 41
  start-page: 1
  year: 1992
  ident: 10.3346/jkms.2017.32.9.1445_ref22
  publication-title: MMWR Recomm Rep
– volume: 118
  start-page: 6226
  year: 2012
  ident: 10.3346/jkms.2017.32.9.1445_ref13
  publication-title: Cancer
  doi: 10.1002/cncr.27694
– volume: 127
  start-page: 1437
  year: 2010
  ident: 10.3346/jkms.2017.32.9.1445_ref12
  publication-title: Int J Cancer
  doi: 10.1002/ijc.25153
– volume: 16
  start-page: 117
  year: 2008
  ident: 10.3346/jkms.2017.32.9.1445_ref18
  publication-title: Top HIV Med
– volume: 43
  start-page: 47
  year: 2006
  ident: 10.3346/jkms.2017.32.9.1445_ref17
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/01.qai.0000232260.95288.93
– volume: 28
  start-page: 990
  year: 2013
  ident: 10.3346/jkms.2017.32.9.1445_ref4
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2013.28.7.990
– ident: 10.3346/jkms.2017.32.9.1445_ref28
– volume: 279
  start-page: 450
  year: 1998
  ident: 10.3346/jkms.2017.32.9.1445_ref2
  publication-title: JAMA
  doi: 10.1001/jama.279.6.450
– volume: 28
  start-page: 67
  year: 2013
  ident: 10.3346/jkms.2017.32.9.1445_ref3
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2013.28.1.67
– volume: 123
  start-page: 187
  year: 2008
  ident: 10.3346/jkms.2017.32.9.1445_ref10
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23487
– volume: 65
  start-page: 463
  year: 2014
  ident: 10.3346/jkms.2017.32.9.1445_ref9
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000000065
– volume: 388
  start-page: 1459
  year: 2016
  ident: 10.3346/jkms.2017.32.9.1445_ref24
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)31012-1
– volume: 92
  start-page: 1823
  year: 2000
  ident: 10.3346/jkms.2017.32.9.1445_ref14
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/92.22.1823
– volume: 30
  start-page: 4360
  year: 2012
  ident: 10.3346/jkms.2017.32.9.1445_ref11
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.44.5486
– volume: 148
  start-page: 728
  year: 2008
  ident: 10.3346/jkms.2017.32.9.1445_ref16
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-148-10-200805200-00005
– volume: 165
  start-page: 416
  year: 2005
  ident: 10.3346/jkms.2017.32.9.1445_ref1
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.165.4.416
– volume: 372
  start-page: 293
  year: 2008
  ident: 10.3346/jkms.2017.32.9.1445_ref23
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)61113-7
– volume: 46
  start-page: 283
  year: 2016
  ident: 10.3346/jkms.2017.32.9.1445_ref27
  publication-title: J Bacteriol Virol
  doi: 10.4167/jbv.2016.46.4.283
– reference: 15234860 - Lancet. 2004 Jul 3-9;364(9428):69-82
– reference: 27733281 - Lancet. 2016 Oct 8;388(10053):1459-1544
– reference: 23091098 - J Clin Oncol. 2012 Dec 10;30(35):4360-6
– reference: 22736272 - Cancer. 2012 Dec 15;118(24):6226-33
– reference: 20049835 - Int J Cancer. 2010 Sep 1;127(6):1437-45
– reference: 15738371 - Arch Intern Med. 2005 Feb 28;165(4):416-23
– reference: 16878047 - J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34
– reference: 18838745 - Top HIV Med. 2008 Oct-Nov;16(4):117-21
– reference: 12008784 - Antivir Ther. 2002 Mar;7(1):21-30
– reference: 24300545 - AIDS. 2014 Mar 27;28(6):881-90
– reference: 23341714 - J Korean Med Sci. 2013 Jan;28(1):67-73
– reference: 20588274 - Br J Cancer. 2010 Jul 27;103(3):416-22
– reference: 23853480 - J Korean Med Sci. 2013 Jul;28(7):990-7
– reference: 26839469 - J Korean Med Sci. 2016 Feb;31(2):178-82
– reference: 18657708 - Lancet. 2008 Jul 26;372(9635):293-9
– reference: 9516219 - N Engl J Med. 1998 Mar 26;338(13):853-60
– reference: 16868446 - AIDS. 2006 Aug 1;20(12):1645-54
– reference: 11078759 - J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30
– reference: 24583616 - J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):463-72
– reference: 9466638 - JAMA. 1998 Feb 11;279(6):450-4
– reference: 16936558 - J Acquir Immune Defic Syndr. 2006 Sep;43(1):47-55
– reference: 1361652 - MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19
– reference: 18490686 - Ann Intern Med. 2008 May 20;148(10):728-36
– reference: 25042234 - Lancet. 2014 Jul 19;384(9939):241-8
– reference: 18435450 - Int J Cancer. 2008 Jul 1;123(1):187-94
SSID ssj0025523
Score 2.1966698
Snippet Since the introduction of highly active antiretroviral therapy, the life span of people with human immunodeficiency virus (HIV) or AIDS (PWHA) has been...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1445
SubjectTerms Acquired Immunodeficiency Syndrome - complications
Acquired Immunodeficiency Syndrome - diagnosis
Adult
Anti-Retroviral Agents - adverse effects
Anti-Retroviral Agents - therapeutic use
Antiretroviral Therapy, Highly Active - adverse effects
Female
HIV Infections - complications
HIV Infections - drug therapy
HIV Infections - pathology
Homosexuality
Humans
Incidence
Liver Neoplasms - diagnosis
Liver Neoplasms - epidemiology
Liver Neoplasms - etiology
Liver Neoplasms - mortality
Lung Neoplasms - diagnosis
Lung Neoplasms - epidemiology
Lung Neoplasms - etiology
Lung Neoplasms - mortality
Lymphoma, Non-Hodgkin - diagnosis
Lymphoma, Non-Hodgkin - epidemiology
Lymphoma, Non-Hodgkin - etiology
Lymphoma, Non-Hodgkin - mortality
Male
Medication Adherence
Middle Aged
Neoplasms - diagnosis
Neoplasms - epidemiology
Neoplasms - etiology
Neoplasms - mortality
Original
Republic of Korea - epidemiology
Retrospective Studies
Sarcoma, Kaposi - diagnosis
Sarcoma, Kaposi - epidemiology
Sarcoma, Kaposi - etiology
Sarcoma, Kaposi - mortality
Survival Rate
Tertiary Care Centers
의학일반
Title Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era
URI https://www.ncbi.nlm.nih.gov/pubmed/28776339
https://www.proquest.com/docview/1926685269
https://pubmed.ncbi.nlm.nih.gov/PMC5546963
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002256308
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Korean Medical Science, 2017, 32(9), 231, pp.1445-1450
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: KQ8
  dateStart: 19860101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: DOA
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals - Free Access to All
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: DIK
  dateStart: 19860101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: 5-W
  dateStart: 19860101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: RPM
  dateStart: 19860101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1598-6357
  dateEnd: 20250831
  omitProxy: true
  ssIdentifier: ssj0025523
  issn: 1011-8934
  databaseCode: M48
  dateStart: 19860901
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELbaIiEuiDfLIzKIIxtlvV6v94BQhFo1VEEcGtSbZWftEiV4281Gor-Av82MvYlaVDhw2kP2FY89841n9vsIeedcIYwrbOq4G6VcO5FWTMsU_KKuCqNZHTSWpl_E8Yx_PivO9shWFbUfwPWtqR3qSc3a1fDn5dVHWPAfMOPMsUK5_IHE21k5zNmwwnJlsU_uQGhiOM2nfFdWAPjMYsd9lqUQqHmkIfrbTZAoWJawAFFJ_FrU2vetuw2Q_tlXeS1QHT0g93uEScdxSjwke9Y_InenfQ39MfkV22DpwtMpgPDzqM-7pkF2iJ40gCI9_RrpVtd0Epq1bE1xw5aGLX86wW9Kmtoi-QR-uUm_LdpNuCGgSYqdI6srOg6OlI59B061w40LeFd6GkkM6GGrn5DZ0eHpp-O0l2NI54BautRpDVjSMAFjko9qybUFr80NcxYGEIBgprkTwham4rWTEPoLZyFEZtpYLUZ5_pQc-Mbb54QaXQOMcOU8E5K7TBojR7rMi9wAWsvKOiFsO9xq3nOVo2TGSkHOguZSaC6F5lI5U5VCcyXk_e6ii0jV8e_T34Id1XK-UEixjcfzRi1bBYnERDFIowohE_Jma2YF6w6LKdrbZrNWgIyFkKjPnpBn0ey7p25nTULKGxNidwI-8OYvfvE9cHtj0yD4xBf_feVLcg__Z2yDe0UOunZjXwNu6swAMobJySDsOgzCuvgNsCYZvg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+Malignancies+among+Korean+Patients+Infected+with+Human+Immunodeficiency+Virus+in+the+Highly+Active+Antiretroviral+Therapy+Era&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Lee%2C+Shinwon&rft.au=Lee%2C+Sun+Hee&rft.au=Lee%2C+Jeong+Eun&rft.au=Kang%2C+Jin+Suk&rft.date=2017-09-01&rft.pub=The+Korean+Academy+of+Medical+Sciences&rft.issn=1011-8934&rft.eissn=1598-6357&rft.volume=32&rft.issue=9&rft.spage=1445&rft.epage=1450&rft_id=info:doi/10.3346%2Fjkms.2017.32.9.1445&rft_id=info%3Apmid%2F28776339&rft.externalDocID=PMC5546963
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon